Article Information
History
- July 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maohua Lib,1,
- Yi Shanc,1,
- Kun Caid,
- Wenlin Renb,
- Hunter Suna,
- Shujiang Wue,
- Jianli Lib,
- Dee Honga,
- Zhenxing Zhange,
- Qi Wangb,
- Lijun Qina,
- Yufei Suna,
- Chunsheng Yee,
- Huan Jianga,
- Zhenyu Wange,
- Yongzhong Jiangd,
- Chao Liub,
- Bin Hud,
- Ruifeng Chenc,* and
- Le Suna,b,*
- aAnyGo Technology Co., Ltd, D1117 New China International Square, 89 Dayangfang Rd, Beijing, China
- bAbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing, China
- cDepartment of Emergency, The Sixth Medical Center of the General Hospital of the People’s Liberation Army, Beijing 100048, P.R. China
- dHubei Provincial Center for Disease Control and Prevention, Wuhan 430079, P. R. China
- eHangzhou Biotest Biotech Co., Ltd, 17 Futai Road, Zhongtai Street, Yuhang District, Hangzhou City, Zhejiang Province, China
- ↵*Co-corresponding Authors: Le Sun, Ph.D. Email: lsun{at}antibodychina.com. AbMax Biotechnology Co., LTD, 99 Kechuang 14th St., BDA, Beijing, China. Ruifeng Chen, MD. Department of Emergency, The Sixth Medical Center of the General Hospital of the People’s Liberation Army, Beijing 100048, P.R. China; Tel: +86 10 66958114, Fax: +86 1066958114, email: cc_rrff{at}126.com
↵1 MH. L. and Y.S. contributed equally to the study as the co-first authors.